BCM
Bayesian Capital Management Portfolio holdings
AUM
$633M
1-Year Return
38.33%
This Quarter Return
+6.05%
1 Year Return
+38.33%
3 Year Return
+146.47%
5 Year Return
+216.79%
10 Year Return
–
AUM
$817M
AUM Growth
-$36.2M
(-4.2%)
Cap. Flow
-$45.7M
Cap. Flow
% of AUM
-5.59%
Top 10 Holdings %
Top 10 Hldgs %
12.04%
Holding
1,060
New
418
Increased
118
Reduced
111
Closed
413
Top Buys
| 1 |
Amgen
AMGN
|
$11.2M |
| 2 |
Salesforce
CRM
|
$9.62M |
| 3 |
Amazon
AMZN
|
$8.67M |
| 4 |
Nike
NKE
|
$8.53M |
| 5 |
Danaher
DHR
|
$7.87M |
Top Sells
| 1 |
Tesla
TSLA
|
$20.8M |
| 2 |
Netflix
NFLX
|
$17.9M |
| 3 |
Chevron
CVX
|
$14.5M |
| 4 |
Fortinet
FTNT
|
$8.82M |
| 5 |
Medtronic
MDT
|
$8.39M |
Sector Composition
| 1 | Technology | 22.56% |
| 2 | Consumer Discretionary | 15.97% |
| 3 | Healthcare | 14.46% |
| 4 | Industrials | 11.44% |
| 5 | Financials | 7.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
626
Porch Group
PRCH
$1.9B
| $62K | 0.01% |
+12,600
| New | +$62K |
|
627
Riskified
RSKD
$726M
| $56.3K | 0.01% |
+11,900
| New | +$56.3K |
|
628
SelectQuote
SLQT
$358M
| $55.1K | 0.01% |
+14,800
| New | +$55.1K |
|
629
American Vanguard Corp
AVD
$159M
| $54.2K | 0.01% |
+11,700
| New | +$54.2K |
|
630
Puma Biotechnology
PBYI
$253M
| $54K | 0.01% |
+17,700
| New | +$54K |
|
631
Nerdy
NRDY
$163M
| $51K | 0.01% |
+31,491
| New | +$51K |
|
632
TELUS International
TIXT
$1.25B
| $45.3K | 0.01% |
+11,555
| New | +$45.3K |
|
|
AMPS
633
DELISTED
Altus Power, Inc.
AMPS
| $44.5K | 0.01% |
+10,922
| New | +$44.5K |
|
634
Denison Mines
DNN
$2.11B
| $44.1K | 0.01% |
+24,500
| New | +$44.1K |
|
635
8x8 Inc
EGHT
$282M
| $42.7K | 0.01% |
+16,000
| New | +$42.7K |
|
636
Biomea Fusion
BMEA
$114M
| $41.9K | 0.01% |
+10,800
| New | +$41.9K |
|
637
Definitive Healthcare
DH
$416M
| $41.3K | 0.01% |
+10,046
| New | +$41.3K |
|
638
Veritone
VERI
$147M
| $39K | ﹤0.01% |
+11,900
| New | +$39K |
|
|
ACCD
639
DELISTED
Accolade, Inc. Common Stock
ACCD
| $37.3K | ﹤0.01% |
10,900
-33,800
| -76% | -$116K |
|
640
Clover Health Investments
CLOV
$1.41B
| $36.9K | ﹤0.01% |
11,716
-25,600
| -69% | -$80.6K |
|
|
ETWO
641
DELISTED
E2open Parent Holdings
ETWO
| $35.4K | ﹤0.01% |
+13,320
| New | +$35.4K |
|
642
Olaplex Holdings
OLPX
$994M
| $35.2K | ﹤0.01% |
20,375
+821
| +4% | +$1.42K |
|
643
Lexicon Pharmaceuticals
LXRX
$396M
| $31K | ﹤0.01% |
+42,000
| New | +$31K |
|
644
Coherus Oncology, Inc. Common Stock
CHRS
$150M
| $19.5K | ﹤0.01% |
+14,100
| New | +$19.5K |
|
645
The Beauty Health Co
SKIN
$260M
| $19K | ﹤0.01% |
11,938
-600
| -5% | -$954 |
|
646
Mersana Therapeutics
MRSN
$34M
| $18K | ﹤0.01% |
+504
| New | +$18K |
|
647
Newegg Commerce
NEGG
$903M
| $4.25K | ﹤0.01% |
+536
| New | +$4.25K |
|
648
PG&E
PCG
$33.2B
| – | – |
-32,709
| Closed | -$647K |
|
649
Pacira BioSciences
PCRX
$1.19B
| – | – |
-27,080
| Closed | -$408K |
|
650
PureCycle Technologies
PCT
$2.41B
| – | – |
-14,315
| Closed | -$136K |
|